These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 16412420)

  • 1. PML-associated repressor of transcription (PAROT), a novel KRAB-zinc finger repressor, is regulated through association with PML nuclear bodies.
    Fleischer S; Wiemann S; Will H; Hofmann TG
    Exp Cell Res; 2006 Apr; 312(6):901-12. PubMed ID: 16412420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
    Tomita A; Buchholz DR; Obata K; Shi YB
    J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.
    Cao T; Duprez E; Borden KL; Freemont PS; Etkin LD
    J Cell Sci; 1998 May; 111 ( Pt 10)():1319-29. PubMed ID: 9570750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KAP1 depletion increases PML nuclear body number in concert with ultrastructural changes in chromatin.
    Kepkay R; Attwood KM; Ziv Y; Shiloh Y; Dellaire G
    Cell Cycle; 2011 Jan; 10(2):308-22. PubMed ID: 21228624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient mutations alter ATRX targeting to PML nuclear bodies.
    Bérubé NG; Healy J; Medina CF; Wu S; Hodgson T; Jagla M; Picketts DJ
    Eur J Hum Genet; 2008 Feb; 16(2):192-201. PubMed ID: 17957225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of PML-dependent transcriptional repression by pRB and low penetrance pRB mutants.
    Fang W; Mori T; Cobrinik D
    Oncogene; 2002 Aug; 21(36):5557-65. PubMed ID: 12165854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
    Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
    J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
    Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel Krüppel-Associated Box identified in a panel of mammalian zinc finger proteins.
    Looman C; Hellman L; Abrink M
    Mamm Genome; 2004 Jan; 15(1):35-40. PubMed ID: 14727140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
    Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
    Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family.
    Nielsen AL; Ortiz JA; You J; Oulad-Abdelghani M; Khechumian R; Gansmuller A; Chambon P; Losson R
    EMBO J; 1999 Nov; 18(22):6385-95. PubMed ID: 10562550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
    Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
    Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies.
    Fuchsová B; Novák P; Kafková J; Hozák P
    J Cell Biol; 2002 Aug; 158(3):463-73. PubMed ID: 12163469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAB-independent suppression of neoplastic cell growth by the novel zinc finger transcription factor KS1.
    Gebelein B; Fernandez-Zapico M; Imoto M; Urrutia R
    J Clin Invest; 1998 Dec; 102(11):1911-9. PubMed ID: 9835615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
    Lehembre F; Müller S; Pandolfi PP; Dejean A
    Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative promoter usage and splicing of ZNF74 multifinger gene produce protein isoforms with a different repressor activity and nuclear partitioning.
    Côté F; Boisvert FM; Grondin B; Bazinet M; Goodyer CG; Bazett-Jones DP; Aubry M
    DNA Cell Biol; 2001 Mar; 20(3):159-73. PubMed ID: 11313019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
    Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
    Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication.
    Jul-Larsen A; Visted T; Karlsen BO; Rinaldo CH; Bjerkvig R; Lønning PE; Bøe SO
    Exp Cell Res; 2004 Aug; 298(1):58-73. PubMed ID: 15242762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.